Martin Shkreli Denied Early Prison Release

Martin Shkreli Denied Early Prison Release
Late last month, pharmaceutical villain Martin Shkreli put in a request to be released early from prison, citing not only his alleged susceptibility to coronavirus due to allergies and asthma, but his supposed unique ability to find a cure for the virus. As of this weekend, his request has been denied.

According to court documents obtained by TMZ, the pharma bro will remain in the custody of FCI Allenwood Low in Pennsylvania — a facility with zero confirmed coronavirus cases — after failing to prove that his request was warranted on any grounds.

As for finding the cure for coronavirus, a New York City judge maintained that vaccines have "so far eluded the best medical and scientific minds in the world working around the clock," calling the presumption that he would be able to help the type of "delusional self-aggrandizing behaviour" that landed him in prison in the first place. Furthermore, the judge rebuked Shkreli's claims that he is more at risk of contracting COVID-19, suggesting that he's not actually asthmatic.

As of now, Shkreli has 40 months left to serve on his sentence.

Back in April, Shkreli put in the request to be released for a three-month furlough to the confinement of his fiancée's apartment in New York City, as well as a request to subsequently serve the remainder of his sentence from home with electronic monitoring.

The 37-year-old first became widely known as a pharmaceutical villain for raising the cost of AIDS and cancer drug Daraprim from $13.50 a tablet to $750 a tablet overnight. From there, his purchase of Wu-Tang Clan's fabled Once Upon a Time in Shaolin and Lil Wayne's Tha Carter V brought him to new levels of notoriety.

Shkreli was sentenced to seven years in prison for defrauding investors in two hedge funds back in 2018.